Under construction – not a live service
Sign in

2024-511821-75-00RecruitingPhase 1/2

Dose escalation of allogeneic Adipose derived Stroma/stem Cells for the treatment of Crohn’s fistula

Source: EU CTIS (euclinicaltrials.eu) · Last updated 2 Feb 2026

Next steps

Status (registry)
Recruiting
Phase (registry)
Phase 1/2
Study type
Interventional
Enrollment
9 (estimated)
First submitted
31 May 2024
Start date
13 Mar 2025
Lead sponsor
Centre Hospitalier Universitaire De Toulouse
EU CT number
2024-511821-75-00

What you commit to

  • Study type: Interventional · Phase 1/2
  • Planned participants: 9
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of EU CTIS (euclinicaltrials.eu). It describes the study design.

AI-kivonat: who the study is looking for

Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.

The trial is looking for adults with Crohn's fistula. It tests different doses of donor fat-derived stem cells.

Age
18 years or older
Sex
All sexes can join

Read by machine on 9 Nov 2026.

Sites (1)

Sites in registry order. Save your city in your profile to sort them by distance.

SiteCityCountrySite status
Centre Hospitalier Universitaire De ToulouseToulouse Cedex 9FranceRecruiting

Are you the coordinator? Confirm the details

This page is information, not medical advice. Discuss any trial with your doctor.